LynxDx careers

LynxDx is a biotechnology company founded to commercialize a groundbreaking prostate cancer diagnostic test, known as MyProstateScore (MPS). This emerged from a genomic discovery made at the University of Michigan, from which the company is spun out of.

As the pandemic emerged in 2020, the company expanded into COVID-19 PCR testing. Since the first test performed in May 2020, the lab grew to one of Michigan’s largest providers of COVID testing. Our COVID testing program is used by the University of Michigan, Detroit Public Schools, local hospitals, community drive-thrus, athletic programs, K-12 schools, and other partners across the State.